Skip to main content
. Author manuscript; available in PMC: 2016 Apr 12.
Published in final edited form as: Bone Marrow Transplant. 2009 Dec 7;45(7):1212–1219. doi: 10.1038/bmt.2009.329

Figure 1. Kaplan Meier estimate of the cumulative incidence of HCMV DNAemia in recipient and/or donor HCMV seropositive patients (n=147).

Figure 1

The cumulative incidence of DNAemia was 15.3 ± 3.0 % at 30 days, 40.1 ± 4.2 % at 60 days, 42.4 ± 4.2 % at 100 days, 48.7 ± 4.4 % at 180 days and 50.7 ± 4.4 % at 360 days. The cross bars indicate censored events.